Viewing Study NCT05946460


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-27 @ 11:53 PM
Study NCT ID: NCT05946460
Status: RECRUITING
Last Update Posted: 2024-02-06
First Post: 2023-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity.
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module